Macrolide-resistant Shigella sonnei

Emerging Infectious Diseases

Volumn 14, Issue 8, 2008, Pages 1297-1299

  Boumghar Bourtchai, Leyla ^a   Mariani Kurkdjian, Patricia ^b   Bingen, Edouard ^b   Filliol, Ingrid ^c   Dhalluin, Anne ^a,d   Ifrane, Shadia Ait ^b   Weill, François Xavier ^c   Leclercq, Roland ^a,e  

^a CHU CÔTE DE NACRE   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c INSTITUT PASTEUR   (France)

^d UNIVERSITÉ DE CAEN   (France)

^e CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; DOXYCYCLINE; MACROLIDE; QUINOLONE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; HUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SHIGELLA SONNEI; SHIGELLOSIS; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DYSENTERY, BACILLARY; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HUMANS; MACROLIDES; PHYLOGENY; POLYMERASE CHAIN REACTION; SHIGELLA SONNEI;

EID: 48749095696     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1408.080147     Document Type: Article

References (15)

1. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, et al. Food-related illness and death in the United States. Emerg Infect Dis. 1999;5:607-25.
2. Centers for Disease Control and Prevention. Outbreaks of multidrug-resistant Shigella sonnei gastroenteritis associated with day care centers - Kansas, Kentucky, and Missouri, 2005. MMWR Morb Mortal Wkly Rep. 2006;55:1068-71.
3. Jain SK, Gupta A, Glanz B, Dick J, Siberry GK. Antimicrobial-resistant Shigella sonnei: limited antimicrobial treatment options for children and challenges of interpreting in vitro azithromycin susceptibility. Pediatr Infect Dis J. 2005;24:494-7. DOI: 10.1097/01.inf.0000164707.13624.a7
4. Gordillo ME, Singh KV, Murray B. In vitro activity of azithromycin against bacterial enteric pathogens. Antimicrob Agents Chemother. 1993;37:1203-5.
5. Gladue RP, Bright GM, Isaacson RE, Newborg MF. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother. 1989;33:277-82.
6. Khan WA, Seas C, Dhar U, Salam MA, Bennish ML. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. Ann Intern Med. 1997;126:697-703.
7. World Health Organization. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1 [cited 2008 Apr 1]. Available from http://whqlibdoc.who.int/publications/2005/9241592330.pdf
8. Garrett V, Bornschlegel K, Lange D, Reddy V, Kornstein L, Komblum J, et al. A recurring outbreak of Shigella sonnei among traditionally observant Jewish children in New York City: the risks of daycare and household transmission. Epidemiol Infect. 2006;134:1231-6. DOI: 10.1017/S0950268806006182
9. Sobel J, Cameron DN, Ismail J, Strockbine N, Williams M, Diaz PS, et al. A prolonged outbreak of Shigella sonnei infections in traditionally observant Jewish communities in North America caused by a molecularly distinct bacterial subtype. J Infect Dis. 1998;177:1405-9.
10. Healy M, Huong J, Bittner T, Lising M, Frye S. Microbial DNA typing by automated repetitive-sequence-based PCR. J Clin Microbiol. 2005;43:199-207. DOI: 10.1128/JCM.43.1.199-207.2005
11. Noguchi N, Emura A, Matsuyama H, O'Hara K, Sasatsu M, Kono M. Nucleotide sequence and characterization of erythromycin resistance determinant that encodes macrolide 2?-phosphotransferase I in Escherichia coli. Antimicrob Agents Chemother. 1995;39:2359-63.
12. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63:219-28. DOI: 10.1016/j.mimet.2005.03.018
13. Szczepanowski R, Krahn I, Linke B, Goesmann A, Pühler A, Schlüter A. Antibiotic multiresistance plasmid pRSB101 isolated from a wastewater treatment plant is related to plasmids residing in phytopathogenic bacteria and carries eight different resistance determinants including a multidrug transport system. Microbiology. 2004;150:3613-30. DOI: 10.1099/mic.0.27317-0
14. Szczepanowski R, Braun S, Riedel V, Schneiker S, Krahn I, Pühler A, et al. The 120 592 bp IncF plasmid pRSB107 isolated from a sewage-treatment plant encodes nine different antibiotic-resistance determinants, two iron-acquisition systems and other putative virulence-associated functions. Microbiology. 2005;151:1095-111. DOI: 10.1099/mic.0.27773-0
15. Rahman M, Shoma S, Rashid H, El Arifeen S, Baqui AH, Siddique AK, et al. Increasing spectrum in antimicrobial resistance of Shigella isolates in Bangladesh: resistance to azithromycin and ceftriaxone and decreased susceptibility to ciprofloxacin. J Health Popul Nutr. 2007;25:158-67.